CPAP treatment
CPAP treatment is a medical device with 21 clinical trials. Currently 5 active trials ongoing. Historical success rate of 85.7%.
Success Metrics
Based on 12 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
80.0%
12 of 15 finished
20.0%
3 ended early
5
trials recruiting
21
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effect of CPAP Treatment in Patients With Severe Uncontrolled Asthma: The ASTHMA-SLEEP Trial
Technology-Supported Treatment of Sleep Apnea in Prediabetes
Effects of PAP Treatment of OSA in Patients With Heart Failure
Optic Nerve Injury in Obstructive Sleep Apnea Patients
Normotensive OSA Patients With Dipper Circadian Blood Pressure Pattern
Clinical Trials (21)
Effect of CPAP Treatment in Patients With Severe Uncontrolled Asthma: The ASTHMA-SLEEP Trial
Technology-Supported Treatment of Sleep Apnea in Prediabetes
Effects of PAP Treatment of OSA in Patients With Heart Failure
Optic Nerve Injury in Obstructive Sleep Apnea Patients
Normotensive OSA Patients With Dipper Circadian Blood Pressure Pattern
XOR Levels in OSA Patients (XOR-OSA)
Masked Hypertensive Patients With Obstructive Sleep Apnea
Normotensive OSA Patients With Nondipper Circadian Blood Pressure Pattern
Early CPAP in COVID-19 Patients With Respiratory Failure.
Prevention Of Delirium in Elderly With Obstructive Sleep Apnea (PODESA)
Sleep-disordered Breathing in Postmenopausal Women
Comparison of Sleep Disordered Breathing Events Detected by the CPAP Device "prismaLine" With Polysomnography
Attentional Capacity and Working Memory in Coronary Artery Disease Patients: Impact of the Presence of a Sleep Apnea Syndrome and Chronic Effects of Treatment With CPAP
Continuous Positive Airway Pressure (CPAP) After Adenotonsillectomy in Children
PAC-IC-SAOS Obstructive Sleep Apnea Syndrome and Ventricular Function
Sleep Apnea in Early to Mid-Stage Alzheimer's Disease
Blood Pressure Reduction Induced by CPAP in Sleep Apnea Patients at High Cardiovascular Risk : OPTISAS 2 Study
Effect of Continuous Positive Airway Pressure Treatment on Inflammation in Patients With Obstructive Sleep Apnea
The Roles of Prostanoids in Patients With Sleep Apnea Syndrome
Alterations in Postprandial Glucose and Lipid Metabolism in Patients With Obstructive Sleep Apnea
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 21